市场调查报告书
商品编码
1380257
全球高级视觉化市场 2023-2030Global Advanced Visualization Market 2023-2030 |
全球高阶视觉化市场根据产品和服务、解决方案类型、影像模式和临床应用进行细分。根据产品和服务,市场分为硬体、软体和服务。根据解决方案类型,市场分为企业版和独立版。根据影像方式,市场分为磁振造影(MRI)、电脑断层扫描(CT)、超音波、核子医学和其他影像方式。根据临床应用,市场分为肿瘤学、骨科、心血管、神经病学和其他临床应用(牙科)。
想像力对于癌症检测和肿瘤科有效实施放射治疗至关重要。因此,先进的可视化技术使医生能够儘早诊断癌症。不同癌症的盛行率不断上升,以及先进视觉化工具技术的不断进步,推动了医疗机构中先进视觉化工具的采用,进而推动了该细分市场的成长。
根据国际癌症研究机构 (IARC) 2021 年 7 月的更新估计,到 2040 年,全球癌症负担预计将增加至 2,750 万新癌症病例和 1,630 万人死亡。如此高的负担将增加对先进可视化的需求,因为它将在识别与癌症盛行率和治疗相关的趋势方面提供显着的好处。
全球高级视觉化市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(义大利、西班牙、德国、法国等)、亚太地区(印度、中国、日本、韩国等)其他)以及世界其他地区(中东、非洲和拉丁美洲)。预计亚太地区将成为全球市场中成长最快的地区。该区域市场的推动因素包括庞大的患者群体、医疗保健设施的技术进步以及医院越来越多地采用先进的软体和服务。
2023 年7 月,ConcertAI 公司Tera Recon 宣布扩大其在澳洲与Change Healthcare 的经销商和服务协议。Change Healthcare 是一家医疗保健IT 供应商,提供创新解决方案以帮助改善医疗保健之旅,并为全球3,500多家诊断影像提供者提供服务。根据扩大后的协议,Change Healthcare 将成为 Intuition 在澳洲的独家经销商,Intuition 是 TeraRecon 与供应商无关的黄金标准高级视觉化解决方案。这些发展进一步促进了区域市场的成长。
该区域市场的推动力是医疗保健环境中先进软体和服务的广泛采用,以提供品质的医疗保健。采取不同成长策略的主要市场参与者的存在进一步推动了区域市场的成长。例如,2022 年 11 月,Ziosoft 为其位于芝加哥的旗舰 Ziostation 系统引入了 revoras 平台。 Revoras 平台(正在进行中)提供了许多生产力增强功能和新的视觉化技术,包括独特的 Ziosoft Rembrandt 影像渲染功能。除了 Rembrandt 观看功能之外,Revoras 平台还提供复杂的协议工作流程,透过加速自动化来加快处理速度并减少培训负担,从而使工作流程变得更加简单。 Revoras 利用平台内人工智慧的力量来优化可重复的结果,帮助更快实现改变生活的治疗。
服务全球先进视觉化市场的主要公司包括: Fujifilm Holdings Corp.、Koninklijke Philips NV、Agfa-Gevaert Group、Canon Medical Systems Corp.)、通用电气公司(GE Healthcare)等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布)为市场成长做出巨大贡献,以维持市场竞争力。例如,2023 年 7 月,美国先进视觉化软体供应商 Mirada Medical 扩大了其嵌入式合作伙伴计划,纳入了世界上第一个成像 EMR OmegaAI 的开发商 RamSoft。与Mirada 的合作意味着RamSoft 的客户已融入全球数千名医疗保健专业人员中,他们目前利用多模态和图像配准工具为用户提供无与伦比的用户体验,并透过先进的直觉式介面存取更多成像资料。
Title: Global Advanced Visualization Market Size, Share & Trends Analysis Report by Product and Service (Hardware, Software, and Services), by Solution Type (Enterprise and Standalone), by Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Medicine, and Other Imaging Modalities), and by Clinical Application (Oncology, Orthopedics, Cardiovascular, Neurology, and Other Clinical Applications (Dental)),Forecast Period (2023-2030).
Global advanced visualization market is anticipated to grow at a significant CAGR of 11.0% during the forecast period. The increasing prevalence of chronic diseases coupled with the growing geriatric population and rising awareness of the benefits associated with advanced visualization tools in disease diagnosis are the key factors driving the growth of the global advanced visualization market. Additionally, the advancements in advanced visualization tools are further contributing to the global market growth. For instance, in October 2022, Align Technology, Inc. introduced iTero-exocad Connector, which integrates iTero intraoral camera and NIRI images within exocad DentalCAD 3.1 Rijeka software. This new integration optimizes design and fabrication of highly esthetic restorations by providing the ability for dental professionals to visualize the internal and external structure of teeth. However, the lack of medical reimbursements for radiology-based diagnostic procedures is restraining the market growth.
The global advanced visualization market is segmented based on product and services, solution type, imaging modality, and clinical application. Based on products and services, the market is segmented into hardware, software, and services. Based on solution type, the market is segmented into enterprise and standalone. Based on imaging modality, the market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), ultrasound, nuclear medicine, and other imaging modalities. Based on clinical application, the market is segmented into oncology, orthopedics, cardiovascular, neurology, and other clinical applications (dental).
Imagining is crucial in cancer detection and for the effective delivery of radiation treatment in oncology departments. Hence, advanced visualization technology enables physicians to diagnose cancers in the earliest stage possible. The growing prevalence of different cancers along with rising technological advancements in advanced visualization tools has driven the adoption of advanced visualization tools in healthcare facilities, which in turn driving the growth of this market segment.
According to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million mortality globally. Such high burdens will increase the demand for advance visualization as it would provide significant benefits in identifying the trend related to the prevalence and treatment of cancer.
The global advanced visualization market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit the highest growth in the global market. The regional market is driven by the presence of a huge patient pool, technical advancement in healthcare facilities, along with the growing adoption of advanced software and services in hospitals.
In July 2023, Tera Recon, a ConcertAI company has announced the expansion of its reseller and service agreement in Australia with Change Healthcare, a healthcare IT provider that delivers innovative solutions to help improve the healthcare journey and serves more than 3,500 diagnostic imaging providers internationally. Under the expanded agreement, Change Healthcare will serve as the sole distributor in Australia for Intuition, TeraRecon's vendor-agnostic, gold standard, advanced visualization solution. Such developments are further contributing to the regional market growth.
The regional market is driven by the high adoption of advanced software and services in healthcare settings to offer quality healthcare. The presence of key market players that are adopting different growth strategies is further driving the regional market growth. For instance, in November 2022, Ziosoft has introduced revoras platform for its flagship Ziostation system in Chicago. The Revoras platform (work in progress) offers numerous productivity enhancements and new visualization technology including the unique Ziosoft Rembrandt image rendering capability. In addition to the Rembrandt viewing capability, the Revoras platform provides complex protocol workflows, which are made simpler using accelerated automation for faster processing and reduced training burdens. Revoras harnesses the power of AI within the platform to optimize the reproducible results, helping to enable life-changing therapies faster.
The major companies serving the global advanced visualization market include: Fujifilm Holdings Corp., Koninklijke Philips N.V., Agfa-Gevaert Group, Canon Inc. (Canon Medical Systems Corp.), General Electric Company (GE Healthcare) among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2023, Mirada Medical, the US based advanced visualization software provider has expanded its embedded partnership program to include RamSoft, developer of the world's first Imaging EMR, OmegaAI. The partnership with Mirada signifies the incorporation of RamSoft customers to the thousands of global healthcare professionals who currently utilize multimodality and image registration tools geared to provide users with an incomparable user experience and access to more imaging data via an advanced intuitive interface.